Latest Polymerase chain reaction Stories
SAN DIEGO, May 20, 2013 /PRNewswire/ -- Dr. Gerald Zon, noted scientist in the field of nucleic acid research, recently launched a new blog in conjunction with TriLink BioTechnologies. The blog, Zone In with Zon (zon.trilinkbiotech.com), focuses on what's trending in the field of nucleic acids. Blog posts include interviews with industry thought leaders, discussions of research presented at conferences and meetings, reviews of current publications and more. Dr. Zon (PhD Princeton...
MANSFIELD, Mass., May 9, 2013 /PRNewswire/ -- PrimeraDx, Inc., a molecular diagnostics company, will be highlighted in a conference call with the Goldman Sachs Healthcare Research Team as part of the GS Emerging Healthcare Series on May 13, 2013 at 11 am. Matthew McManus, MD, Ph.D., President and CEO of PrimeraDx will provide an overview of the Company's innovative technology and its two-pronged approach to the market: offering an "open platform" system to reference labs, academic...
SAN DIEGO, May 9, 2013 /PRNewswire/ -- TriLink BioTechnologies, Inc. (TriLink, www.trilinkbiotech.com), a leader in manufacturing high quality oligonucleotides, nucleoside triphosphates and mRNA, announced that it has signed a licensing agreement with QuantiBact A/S (QuantiBact, www.quantibact.com) to offer twisted intercalating nucleic acid (TINA) modified oligos. TINA molecules are intercalators placed at the 5' end of primers to stabilize duplex formation. Their unique properties...
Superior Accuracy and On-Demand Validated Assays Covering the Whole Exome Enable Major Clinical Sequencing Providers FREMONT, Calif., May 9, 2013 /PRNewswire/ -- WaferGen Bio-systems, Inc. (OTCBB: WGBS) today announced the launch of its new SmartChip TE product - a PCR-based target enrichment solution for sample preparation prior to targeted re-sequencing on Next-Gen platforms. As clinical Next-Gen sequencing rapidly expands into the mainstream molecular testing market, the growth...
Novel method to enrich microbial genomic DNA for more affordable microbiome next generation DNA sequencing IPSWICH, Mass., May 8, 2013 /PRNewswire/ -- New England Biolabs (NEB) announces the release of the NEBNext(®) Microbiome DNA Enrichment Kit, which uses a novel method to separate microbial DNA from host DNA, thereby reducing the high cost of sequencing microbiome DNA to a more practical level. (Logo: http://photos.prnewswire.com/prnh/20090921/NE79207LOGO-b ) Microbiome...
AMRESCO’s Fluorescent DNA Quantitation Kit quantifies double-stranded DNA in the low nanogram up to 5 microgram per ml range using fluorescent bisBenzimide H33258 (Hoechst) dye. Solon, Ohio (PRWEB) May 06, 2013 DNA quantitation is crucial to experimental design and interpretation of results, especially in sensitive molecular biology applications such as PCR, or for any comparative analysis of multi-source DNA samples. Although UV spectrophotometric measurement at 260 nm is the most...
IPSWICH, Mass. and NORTHAMPTON, Mass., May 1, 2013 /PRNewswire/ -- This summer, Smith College is hosting the 28(th) annual Molecular Biology Summer Workshops at the Ford Science Center in Northampton, MA. In cooperation with New England Biolabs (NEB), a leader in the research and development of reagents for the life sciences, Smith College invites interested parties to learn molecular biology in this intensive workshop, set against the peaceful and picturesque backdrop of the Smith...
MOUNTAIN VIEW, Calif., May 1, 2013 /PRNewswire/ -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the release of the SMARTer Universal Low Input RNA Kit for Sequencing. The SMARTer Universal Low Input RNA Kit extends Clontech's NGS (Next Generation Sequencing) solutions to include low input samples of compromised RNA. It combines Clontech's patented SMART(TM) (Switching Mechanism at 5' End of RNA Template) technology for ds cDNA synthesis...
ReportsnReports.com offers 2013 market research reports on trends in qPCR Assay, phenotypic drug discovery, benchtop automation and mass spectrometry (MS)-based screening assays. DALLAS, May 1, 2013 /PRNewswire-iReach/ -- qPCR Assay Trends 2013, Phenotypic Drug Discovery Trends 2013, Benchtop Automation Trends 2013 and Mass Spec-Based Screening Assay Trends 2013 are new reports available with ReportsnReports.com (Photo: http://photos.prnewswire.com/prnh/20130501/CG04491)...
Company's instruments FDA-cleared under Emergency Use Authorization declaration CARLSBAD, Calif., April 26, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced that its Applied Biosystems® 7500 Fast Dx Real-Time PCR instrument is the sole platform cleared for use under the Centers for Disease Control and Prevention (CDC) protocol created for emergency screenings of patients suspected of harbouring the Avian influenza (H7N9) virus, which to date has led...
